Literature DB >> 4018422

Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria.

J J Bending, G C Viberti, R W Bilous, H Keen.   

Abstract

Persistent Albustix-positive proteinuria and subsequent chronic renal failure are frequently encountered in insulin-dependent diabetes mellitus (IDDM). Rates of decline of renal function may be modified by treatment of accompanying hypertension, but studies of the effects of long-term continuous subcutaneous insulin infusion (CSII) on deterioration of renal function provide no statistically significant evidence of benefit of near-normoglycemia. However, short-term studies in IDDM subjects with negative Albustix tests but subclinically raised levels of albumin excretion rate (AER) have shown that treatment with CSII significantly reduces this microalbuminuria. The prospective, controlled 8-mo Kroc Collaborative Study therefore offered the opportunity of examining more protracted effects of CSII-induced metabolic correction upon microalbuminuria. Twenty-four-hour urine collections obtained at baseline, 4, and 8 mo were available from 59 Albustix-negative patients. Beta 2-microglobulin excretion was normal. The 39 normoalbuminuric (AER less than 12 micrograms/min) patients did not differ from the 20 microalbuminuric (AER elevated between 13.2 and 192.6 micrograms/min) with respect to distributions of age, sex, and duration of diabetes. In both the normoalbuminuric and the microalbuminuric groups studied at 4 and 8 mo, percent glycosylated hemoglobin (%HbA1) and mean blood glucose were significantly decreased during CSII compared with baseline values, whereas no change occurred in the group continuing their conventional insulin therapy (CIT). AER did not differ between CIT and CSII treatments in the normoalbuminuric group. AER fell significantly in the CSII-treated microalbuminuric patients at 4 (P less than 0.05) and 8 (P less than 0.01) mo but showed no consistent change in the CIT microalbuminuric group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4018422     DOI: 10.2337/diab.34.3.s69

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

2.  'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy.

Authors:  R Miccoli; O Giampietro; G Penno; G Odello; R Anichini; A Bertolotto; L Cruschelli; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

3.  The pathogenesis and prevention of diabetic nephropathy.

Authors:  R Omachi
Journal:  West J Med       Date:  1986-08

Review 4.  Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

Authors:  K G Dawson; J K McKenzie; S A Ross; J L Chiasson; P Hamet
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

5.  Correlation between urinary activity of N-acetyl-beta-D-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects.

Authors:  G Perdichizzi; D Cucinotta; R Fera; E Di Cesare; S Campo; G Squadrito
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

6.  Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.

Authors:  E Chantelau; M Spraul; I Mühlhauser; R Gause; M Berger
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

7.  Urinary protein excretion rates in experimentally diabetic dogs and experimentally galactosaemic dogs.

Authors:  T S Kern; R L Engerman
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 8.  Hemodynamic factors in the pathogenesis of diabetic nephropathy.

Authors:  R W Schrier; H Holzgreve
Journal:  Klin Wochenschr       Date:  1988-04-15

9.  Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

Authors:  H H Parving; E Hommel; E Mathiesen; P Skøtt; B Edsberg; M Bahnsen; M Lauritzen; P Hougaard; E Lauritzen
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

Review 10.  Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Authors:  Pernille Kähler; Berit Grevstad; Thomas Almdal; Christian Gluud; Jørn Wetterslev; Søren Søgaard Lund; Allan Vaag; Bianca Hemmingsen
Journal:  BMJ Open       Date:  2014-08-19       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.